WPRT Westport Innovations Inc gains 28% May 29, 2020

Westport Fuel Systems Inc., a transportation technology company, provides low-emission engine and fuel system technologies utilizing gaseous fuels in North America, Europe, Asia, and South America. The company operates in four segments: Automotive, Industrial, Corporate and Technology Investments, and Cummins Westport Joint Venture. It designs, manufactures, and sells compressed natural gas (CNG), liquefied petroleum gas (LPG), and liquefied natural gas (LNG) components and systems to original equipment manufacturers and aftermarket customers. The company also designs, manufactures, tests, certifies, and sells components, such as pressure regulators, injectors, electronic control units, valves, filters, and bi-fuel, mono-fuel, and dual-fuel LPG and CNG conversion kits under the BRC Gas Equipment, Emer, OMVL, Valtek, Prins, Zavoli, GFI, and TA Gas Technology brands; fuel system components include vaporizers, and CNG and LPG tank valves; CUBOGAS branded CNG compressors and refueling systems; LPG injection systems; diesel and CNG engines; natural gas fuel systems; and Westport WiNG power system vehicles. In addition, it designs and manufactures alternative fuel components and systems for off-road mobile and stationary equipment, and heavy-duty on-road vehicles, as well as develops complete emissions certified and non-certified engines for forklifts and other industrial equipment under the IMPCO, Westport, and GFI brands. Further, the company offers natural gas engines for transit, school, and shuttle buses; conventional trucks and tractors; refuse collection trucks; and specialty vehicles, such as short-haul port drayage trucks and street sweepers. The company was formerly known as Westport Innovations Inc. and changed its name to Westport Fuel Systems Inc. in June 2016. The company was founded in 1995 and is headquartered in Vancouver, Canada.http://www.priceseries.com/trade/WPRT-Westport-Innovations-Inc-stock-gains-28-percent-a-Trade-Record-by-priceSeries-2020050820200529.html

TRIL Trillium Therapeutics Inc. gains 36% May 22, 2020

Trillium Therapeutics Inc., a biopharmaceutical development company, advances cancer stem cell discoveries into novel and cancer therapies in Canada. Its products comprise Tigecycline, an antibiotic, which is in phase I for study in patients with relapsed or refractory acute myeloid leukemia (AML); SIRPaFc, an antibody-like fusion protein, which is in pre-clinical stage that blocks the activity of CD47, a molecule that is upregulated on cancer stem cells in AML and other tumors; CD200, a human monoclonal antibody that blocks the activity of CD200, an immunosuppressive molecule; and TTI-1612, a recombinant soluble for the treatment of interstitial cystitis (IC), a chronic bladder disease characterized by low urinary HB-EGF levels and a dysfunctional, which recently completed a 28-patient Phase I trial in IC patients. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was founded in 2004 and is headquartered in Toronto, Canada.http://www.priceseries.com/trade/TRIL-Trillium-Therapeutics-Inc-stock-gains-36-percent-a-Trade-Record-by-priceSeries-2020050120200522.html

SKYS Sky Solar Holdings, Ltd. gains 101% May 29, 2020

Sky Solar Holdings, Ltd., an independent power producer, develops, owns, and operates solar parks worldwide. It develops projects; and generates and sells electricity in the downstream solar market. The company also sells solar energy systems, including pipeline and related engineering, construction, and procurement services, as well as is involved in building and transferring solar parks. In addition, it provides operating and maintenance services for solar parks; and sells solar modules. As of December 31, 2015, the company developed 273 solar parks with an aggregate capacity of 252.8 megawatts in Greece, Japan, Bulgaria, the Czech Republic, Spain, Canada, the United States, Germany and Uruguay; and owned and operated 128.6 MW of solar parks. It also had 28.2 megawatts of solar parks under construction, 238.2 megawatts of shovel-ready projects, and 1.0 gigawatt of solar parks in pipeline. Sky Solar Holdings, Ltd. was founded in 2009 and is headquartered in Central, Hong Kong. Sky Solar Holdings, Ltd. is a subsidiary of Sky Power Group Ltd.http://www.priceseries.com/trade/SKYS-Sky-Solar-Holdings-Ltd-stock-gains-101-percent-a-Trade-Record-by-priceSeries-2020042820200529.html

QDEL Quidel Corp. gains 58% May 22, 2020

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC women's and general health, and gastrointestinal diseases. The company offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus (RSV), QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S. Pneomoniae fluorescent immunoassay (FIA) to detect pneumococcal pneumonia and meningitis; Sofia Legionella FIA to detect Legionella pneumophila seorgroup 1 antigen; AmpliVue Bordetella assay to detect Bordetella pertussis; and Lyra Adenovirus assay to detect human adenovirus viral DNA. In addition, the company offers Sofia hCG fluorescent immunoassay and QuickVue pregnancy tests to detect hCG in serum or urine; Thyretain for the diagnosis of graves disease; QuickVue Chlamydia test to detect Chlamydia trachomatis; Solana Trichomonas assay for the diagnosis of trichomoniasis; and clinical and research products for the assessment of osteoporosis and evaluation of bone resorption/formation. Further, it provides Lyra Direct C. difficile assay to detect Clostridium difficile Toxin A or Toxin B genes; Super E-Mix and D3 IFA Enterovirus indirect fluorescent antibody products; QuickVue fecal immunochemical test to detect the presence of blood in stool specimens; and serological tests to measure antibodies circulating in the blood. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.http://www.priceseries.com/trade/QDEL-Quidel-Corp-stock-gains-58-percent-a-Trade-Record-by-priceSeries-2020042020200522.html

ONCS OncoSec Medical Incorporated gains 15% May 29, 2020

OncoSec Medical Incorporated, a biotechnology company, designs, develops, and commercializes gene therapies, therapeutics, and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer in the United States. Its lead product candidate is the ImmunoPulse IL-12, which is in Phase II clinical trial for various indications, including metastatic melanoma and triple negative breast cancer. ImmunoPulse is an electroporation delivery device used in combination with the company's therapeutic product candidates, including DNA plasmids that encode for immunologically active agents, and to deliver the therapeutic directly into the tumor and promote an inflammatory response against the cancer. The company also has completed two Phase II studies for products, such as OMS-I100 in metastatic melanoma and OMS-I110 in merkel cell carcinoma. It has a clinical collaboration with the University of California, San Francisco to evaluate the safety and efficacy of ImmunoPulse IL-12 in combination with KEYTRUDA (pembrolizumab) in patients with low tumor-infiltrating lymphocyte. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. OncoSec Medical Incorporated was incorporated in 2008 and is headquartered in San Diego, California.http://www.priceseries.com/trade/ONCS-OncoSec-Medical-Incorporated-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020051820200529.html

NWHM New Home Company Inc. (The) gains 23% May 29, 2020

The New Home Company Inc., a homebuilder, focuses on the design, construction, and sale of homes in metropolitan areas of California and Arizona. The company operates through two segments, Homebuilding and Fee Building. It builds and sells homes in California, including coastal Southern California, the San Francisco Bay area, the metro Sacramento, and the Phoenix area. The company also offers general contracting services to build homes for independent third-party property owners. The New Home Company Inc. was founded in 2009 and is headquartered in Aliso Viejo, California.http://www.priceseries.com/trade/NWHM-New-Home-Company-Inc-The-stock-gains-23-percent-a-Trade-Record-by-priceSeries-2020051520200529.html

NSS NuStar Logistics, L.P. gains 44% May 29, 2020

NuStar Logistics, L.P. engages in the terminalling, storage, and transportation of petroleum products; the transportation of anhydrous ammonia; and the refining and marketing of petroleum. The company operates in three segments: Storage, Transportation, and Asphalt and Fuels Marketing. The Storage segment operates terminal and storage facilities that provide storage and handling services for petroleum products, specialty chemicals, crude oil and other feedstocks, and other liquids; and storage tanks that are used to store and deliver crude oil. This segment also provides various services, such as blending, filtering, pilotage, tug assistance, line handling, launch, emergency response, and other ship services. The Transportation segment transports refined petroleum products, crude oil, and anhydrous ammonia. The Asphalt and Fuels Marketing segment refines crude oil to produce asphalt and certain other refined products; and purchases crude oil and other refined petroleum products for resale. NuStar Logistics serves producers of crude oil, integrated oil companies, chemical companies, oil traders and refiners, farm cooperatives, railroads, and road and bridge construction companies. The company is headquartered in San Antonio, Texas. NuStar Logistics, L.P. is a subsidiary of Nustar Energy L.P.http://www.priceseries.com/trade/NSS-NuStar-Logistics-LP-stock-gains-44-percent-a-Trade-Record-by-priceSeries-2020040820200529.html

NINE Nine Energy Service, Inc. gains 28% May 22, 2020

http://www.priceseries.com/trade/NINE-Nine-Energy-Service-Inc-stock-gains-28-percent-a-Trade-Record-by-priceSeries-2020050720200522.html

INSM Insmed, Inc. gains 25% May 29, 2020

Insmed Incorporated, a biopharmaceutical company, focuses on the development and commercialization of therapies for patients with rare diseases. The company's lead product candidate is ARIKAYCE or liposomal amikacin for inhalation, a formulation of amikacin that is in late-stage clinical development for adult patients with treatment refractory nontuberculous mycobacteria lung disease caused by Mycobacterium avium complex. It is also developing INS1007, a novel oral reversible inhibitor of dipeptidyl peptidase 1, which has completed a Phase I clinical study for activating neutrophil serine proteases that are implicated in the pathology of chronic inflammatory lung diseases, such as non-cystic fibrosis bronchiectasis; and INS1009, an inhaled nanoparticle formulation of a treprostinil prodrug, which has completed a Phase I clinical study for treating rare pulmonary disorders, including pulmonary arterial hypertension. The company was founded in 1999 and is headquartered in Bridgewater, New Jersey.http://www.priceseries.com/trade/INSM-Insmed-Inc-stock-gains-25-percent-a-Trade-Record-by-priceSeries-2020041720200529.html

DVAX Dynavax Technologies Corp. gains 22% May 22, 2020

Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. The company's lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, an investigational cancer immunotherapeutic that is in Phase I/II studies. Its product candidates also comprise AZD1419, which is in Phase II clinical trial for the treatment of asthma; DV230F that is in preclinical stage for the treatment of liver tumors; and DV1001, a TLR 7&8 agonist, which is in preclinical stage for the treatment of for multiple malignancies, as well as DV281 for the treatment of non-small cell lung cancer. It has collaboration and license agreements with AstraZeneca AB to develop AZD1419 for the treatment of asthma; and Merck & Co. to develop SD-101 for varios immuno-oncology therapies. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.http://www.priceseries.com/trade/DVAX-Dynavax-Technologies-Corp-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2020051420200522.html

CBAY Cymabay Therapeutics Inc. gains 102% May 29, 2020

Cymabay Therapeutics, Inc. focuses on developing therapies to treat metabolic diseases. Its key clinical development candidates comprise MBX-8025, a selective agonist that is in a third Phase II clinical trial in patients with primary biliary cholangitis; and Arhalofenate, which completed five Phase II clinical trials for the treatment of gout. The company's product candidate also includes MBX-2982, an oral, G-protein coupled receptor agonist to treat type II diabetes. Cymabay Therapeutics, Inc. has a development and license agreements with Janssen Pharmaceuticals, Inc. to develop and discover undisclosed metabolic disease target agonists for the treatment of type II diabetes and other disorders; and a license and development agreement with DiaTex, Inc. to develop and commercialize therapeutic products. The company was formerly known as Metabolex, Inc. Cymabay Therapeutics, Inc. was incorporated in 1988 and is based in Newark, California.http://www.priceseries.com/trade/CBAY-Cymabay-Therapeutics-Inc-stock-gains-102-percent-a-Trade-Record-by-priceSeries-2020051120200529.html

TRIL Trillium Therapeutics Inc. gains 36% May 22, 2020

Trillium Therapeutics Inc., a biopharmaceutical development company, advances cancer stem cell discoveries into novel and cancer therapies in Canada. Its products comprise Tigecycline, an antibiotic, which is in phase I for study in patients with relapsed or refractory acute myeloid leukemia (AML); SIRPaFc, an antibody-like fusion protein, which is in pre-clinical stage that blocks the activity of CD47, a molecule that is upregulated on cancer stem cells in AML and other tumors; CD200, a human monoclonal antibody that blocks the activity of CD200, an immunosuppressive molecule; and TTI-1612, a recombinant soluble for the treatment of interstitial cystitis (IC), a chronic bladder disease characterized by low urinary HB-EGF levels and a dysfunctional, which recently completed a 28-patient Phase I trial in IC patients. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was founded in 2004 and is headquartered in Toronto, Canada.http://www.priceseries.com/trade/TRIL-Trillium-Therapeutics-Inc-stock-gains-36-percent-a-Trade-Record-by-priceSeries-2020050120200522.html

QDEL Quidel Corp. gains 58% May 22, 2020

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC women's and general health, and gastrointestinal diseases. The company offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus (RSV), QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S. Pneomoniae fluorescent immunoassay (FIA) to detect pneumococcal pneumonia and meningitis; Sofia Legionella FIA to detect Legionella pneumophila seorgroup 1 antigen; AmpliVue Bordetella assay to detect Bordetella pertussis; and Lyra Adenovirus assay to detect human adenovirus viral DNA. In addition, the company offers Sofia hCG fluorescent immunoassay and QuickVue pregnancy tests to detect hCG in serum or urine; Thyretain for the diagnosis of graves disease; QuickVue Chlamydia test to detect Chlamydia trachomatis; Solana Trichomonas assay for the diagnosis of trichomoniasis; and clinical and research products for the assessment of osteoporosis and evaluation of bone resorption/formation. Further, it provides Lyra Direct C. difficile assay to detect Clostridium difficile Toxin A or Toxin B genes; Super E-Mix and D3 IFA Enterovirus indirect fluorescent antibody products; QuickVue fecal immunochemical test to detect the presence of blood in stool specimens; and serological tests to measure antibodies circulating in the blood. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.http://www.priceseries.com/trade/QDEL-Quidel-Corp-stock-gains-58-percent-a-Trade-Record-by-priceSeries-2020042020200522.html

OBSV obsEva SA gains 63% May 28, 2020

N/Ahttp://www.priceseries.com/trade/OBSV-obsEva-SA-stock-gains-63-percent-a-Trade-Record-by-priceSeries-2020050420200528.html

NINE Nine Energy Service, Inc. gains 28% May 22, 2020

http://www.priceseries.com/trade/NINE-Nine-Energy-Service-Inc-stock-gains-28-percent-a-Trade-Record-by-priceSeries-2020050720200522.html

KEM Kemet Corp. gains 19% May 28, 2020

KEMET Corporation, together with its subsidiaries, manufactures and sells passive electronic components under the KEMET brand worldwide. The company operates through two segments, Solid Capacitors, and Film and Electrolytic. Its products include tantalum, multilayer ceramic, film, electrolytic, paper, and solid aluminum capacitors, as well as EMI filters. The company offers its capacitors for use in the automotive, communications, computer-related, industrial, consumer, military/aerospace, and alternative energy industries. KEMET Corporation sells its products to original equipment manufacturers, electronics manufacturing services providers, and electronics distributors. The company was founded in 1919 and is headquartered in Simpsonville, South Carolina.http://www.priceseries.com/trade/KEM-Kemet-Corp-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2020032420200528.html

ISSC Innovative Solutions and Support, Inc. gains 22% May 28, 2020

Innovative Solutions and Support, Inc., a systems integrator, designs, manufactures, sells, and services flight guidance and cockpit display systems. It offers flat panel display systems that could replicate the display of analog or digital displays on one screen and could replace existing displays in legacy aircraft, as well as used for security monitoring on-board aircraft and as tactical workstations on military aircraft; flight management systems that complement the IS&S flat panel display system upgrade for commercial air transport aircraft; and integrated standby units, which incorporate the measurement and display of attitude, altitude, airspeed, and navigation data into a single standby/backup navigation instrument for military, commercial air transport, and corporate/general aviation applications. The company also provides digital air data computers, which calculate various air data parameters, such as altitude, airspeed, vertical speed, angle of attack, and other information derived from the measure of air pressure; integrated air data computers and display units that calculate and convey air data information; altitude displays, which convey aircraft altitude measurements; airspeed displays, which convey various types of airspeed measurements; and altitude alerters that allow pilots to select a desired cruising altitude and provide warnings to pilots when an unacceptable deviation occurs. In addition, it offers engine and fuel displays that convey information related to fuel and oil levels, and engine activity, such as oil and hydraulic pressure and temperature; and integrated global navigation systems. The company serves commercial air transport carriers and corporate/general aviation companies, Department of Defense and its commercial contractors, aircraft operators, aircraft modification centers, foreign militaries, and original equipment manufacturers. Innovative Solutions and Support, Inc. was founded in 1988 and is based in Exton, Pennsylvania.http://www.priceseries.com/trade/ISSC-Innovative-Solutions-and-Support-Inc-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2020050720200528.html

DVAX Dynavax Technologies Corp. gains 22% May 22, 2020

Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. The company's lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, an investigational cancer immunotherapeutic that is in Phase I/II studies. Its product candidates also comprise AZD1419, which is in Phase II clinical trial for the treatment of asthma; DV230F that is in preclinical stage for the treatment of liver tumors; and DV1001, a TLR 7&8 agonist, which is in preclinical stage for the treatment of for multiple malignancies, as well as DV281 for the treatment of non-small cell lung cancer. It has collaboration and license agreements with AstraZeneca AB to develop AZD1419 for the treatment of asthma; and Merck & Co. to develop SD-101 for varios immuno-oncology therapies. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.http://www.priceseries.com/trade/DVAX-Dynavax-Technologies-Corp-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2020051420200522.html

CRL Charles River Laboratories Intl., Inc. gains 15% May 27, 2020

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening preclinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs and chickens used in the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.http://www.priceseries.com/trade/CRL-Charles-River-Laboratories-Intl-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020050620200527.html

AMCX AMC Networks Inc. gains 20% May 28, 2020

AMC Networks Inc. owns and operates various cable television's brands delivering content to audiences, and a platform to distributors and advertisers in the United States and internationally. The company operates in two segments, National Networks; and International and Other. The National Networks segment operates five distributed entertainment programming networks under the AMC, WE tv, BBC AMERICA, IFC, and SundanceTV names in high definition and standard definition formats. This segment distributes its networks in the United States through cable and other multichannel video programming distribution platforms, including direct broadcast satellite and platforms operated by telecommunications providers. The International and Other segment delivers entertaining and acclaimed programming services for subscribers in approximately 140 countries and territories, including Europe, Latin America, the Middle East, and the parts of Asia and Africa. This segment also operates in independent film distribution business that distributes films across various media platforms, including theaters, cable/satellite video on demand, DVDs and cable network television, and streaming/downloading to computers and other electronic devices. AMC Networks Inc. was founded in 1980 and is headquartered in New York, New York.http://www.priceseries.com/trade/AMCX-AMC-Networks-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2020050620200528.html

AKBA Akebia Therapeutics, Inc. gains 34% May 28, 2020

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product candidates that include AKB-6899 for the treatment of anemia; and AKB-5169, a preclinical compound for the treatment for inflammatory bowel disease. Akebia Therapeutics, Inc. has collaboration agreements with Otsuka Pharmaceutical Co. Ltd. for the development and commercialization of vadadustat in the United States, as well as with Mitsubishi Tanabe Pharma Corporation for the development and commercialization to vadadustat in Japan and other Asian countries. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts.http://www.priceseries.com/trade/AKBA-Akebia-Therapeutics-Inc-stock-gains-34-percent-a-Trade-Record-by-priceSeries-2020050420200528.html

TRIL Trillium Therapeutics Inc. gains 36% May 22, 2020

Trillium Therapeutics Inc., a biopharmaceutical development company, advances cancer stem cell discoveries into novel and cancer therapies in Canada. Its products comprise Tigecycline, an antibiotic, which is in phase I for study in patients with relapsed or refractory acute myeloid leukemia (AML); SIRPaFc, an antibody-like fusion protein, which is in pre-clinical stage that blocks the activity of CD47, a molecule that is upregulated on cancer stem cells in AML and other tumors; CD200, a human monoclonal antibody that blocks the activity of CD200, an immunosuppressive molecule; and TTI-1612, a recombinant soluble for the treatment of interstitial cystitis (IC), a chronic bladder disease characterized by low urinary HB-EGF levels and a dysfunctional, which recently completed a 28-patient Phase I trial in IC patients. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was founded in 2004 and is headquartered in Toronto, Canada.http://www.priceseries.com/trade/TRIL-Trillium-Therapeutics-Inc-stock-gains-36-percent-a-Trade-Record-by-priceSeries-2020050120200522.html

SQ Square, Inc. gains 20% May 27, 2020

Mobile payment service provider for small businesses.http://www.priceseries.com/trade/SQ-Square-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2020050420200527.html

SHOP Shopify Inc. gains 76% May 27, 2020

Shopify Inc. provides a cloud-based multi-channel commerce platform for small and medium-sized businesses in Canada, the United States, the United Kingdom, Australia, and internationally. Its platform provides merchants with a single view of their business and customers in various sales channels, including Web and mobile storefronts, physical retail locations, social media storefronts, and marketplaces; and enables them to manage products and inventory, process orders and payments, ship orders, build customer relationships, and leverage analytics and reporting. The company was formerly known as Jaded Pixel Technologies Inc. and changed its name to Shopify Inc. in November 2011. Shopify Inc. was founded in 2004 and is headquartered in Ottawa, Canada.http://www.priceseries.com/trade/SHOP-Shopify-Inc-stock-gains-76-percent-a-Trade-Record-by-priceSeries-2020040820200527.html

QDEL Quidel Corp. gains 58% May 22, 2020

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications primarily in infectious diseases, POC women's and general health, and gastrointestinal diseases. The company offers Sofia influenza A+B and QuickVue influenza tests to detect viral antigens of influenza type A and B; Sofia strep A fluorescent immunoassay and QuickVue Strep A tests to detect group A Streptococcal antigen from throat swabs; and Sofia Respiratory Syncytial Virus (RSV), QuickVue RSV, and Quidel Molecular RSV + human metapneumovirus tests for respiratory syncytial virus. It also provides various products to detect various herpes simplex virus (HSV) and herpes family viruses; H&V-Mix to isolate HSV, VZV, and Cytomegalovirus; R-Mix to detect Influenza A and B, RSV, Adenovirus, and Parainfluenza types 1, 2, and 3; Sofia S. Pneomoniae fluorescent immunoassay (FIA) to detect pneumococcal pneumonia and meningitis; Sofia Legionella FIA to detect Legionella pneumophila seorgroup 1 antigen; AmpliVue Bordetella assay to detect Bordetella pertussis; and Lyra Adenovirus assay to detect human adenovirus viral DNA. In addition, the company offers Sofia hCG fluorescent immunoassay and QuickVue pregnancy tests to detect hCG in serum or urine; Thyretain for the diagnosis of graves disease; QuickVue Chlamydia test to detect Chlamydia trachomatis; Solana Trichomonas assay for the diagnosis of trichomoniasis; and clinical and research products for the assessment of osteoporosis and evaluation of bone resorption/formation. Further, it provides Lyra Direct C. difficile assay to detect Clostridium difficile Toxin A or Toxin B genes; Super E-Mix and D3 IFA Enterovirus indirect fluorescent antibody products; QuickVue fecal immunochemical test to detect the presence of blood in stool specimens; and serological tests to measure antibodies circulating in the blood. Quidel Corporation was founded in 1979 and is headquartered in San Diego, California.http://www.priceseries.com/trade/QDEL-Quidel-Corp-stock-gains-58-percent-a-Trade-Record-by-priceSeries-2020042020200522.html

OKTA Okta, Inc. gains 15% May 27, 2020

N/Ahttp://www.priceseries.com/trade/OKTA-Okta-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020050420200527.html

NVDA NVIDIA Corp. gains 15% May 27, 2020

NVIDIA Corporation operates as a visual computing company worldwide. It operates in two segments, GPU and Tegra Processor. The GPU segment offers processors, which include GeForce for PC gaming; GeForce NOW for cloud-based game-streaming service; Quadro for design professionals working in computer-aided design, video editing, special effects, and other creative applications; Tesla for deep learning, accelerated computing, and general purpose computing; and GRID for cloud-based visual computing users. The Tegra Processor segment provides processors that integrate a computer onto a single chip under the Tegra brand name; DRIVE automotive computers, which offer self-driving capabilities; and tablet and portable devices for mobile gaming and TV streaming under the SHIELD name. The company's products are used in gaming, professional visualization, datacenter, and automotive markets. It sells its products primarily to original equipment manufacturers, original device manufacturers, system builders, motherboard manufacturers, add-in board manufacturers, and retailers/distributors. NVIDIA Corporation was founded in 1993 and is headquartered in Santa Clara, California.http://www.priceseries.com/trade/NVDA-NVIDIA-Corp-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020050420200527.html

NVAX Novavax, Inc. gains 124% May 27, 2020

Novavax, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. The company develops respiratory syncytial virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III development stage; older adults in Phase II development stage; and children six months to five years of age in Phase I development stage. It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.http://www.priceseries.com/trade/NVAX-Novavax-Inc-stock-gains-124-percent-a-Trade-Record-by-priceSeries-2020050820200527.html

NINE Nine Energy Service, Inc. gains 28% May 22, 2020

http://www.priceseries.com/trade/NINE-Nine-Energy-Service-Inc-stock-gains-28-percent-a-Trade-Record-by-priceSeries-2020050720200522.html

FTNT Fortinet, Inc. gains 26% May 27, 2020

Fortinet, Inc. provides cybersecurity solutions for enterprises, service providers, and government organizations worldwide. The company offers FortiGate physical and software licenses that provide various security and networking functions, including firewall, intrusion prevention, anti-malware, virtual private network, application control, Web filtering, anti-spam, and wide area network acceleration; FortiManager product family to provide a central management solution for FortiGate products comprising software updates, configuration, policy settings, and security updates; and the FortiAnalyzer product family, which offers a single point of network log data collection. It also provides FortiAP secure wireless access points; FortiWeb, a Web application firewall; FortiMail email security; FortiDB database security appliances; FortiClient, an endpoint security software; and FortiSwitch secure switch connectivity products. In addition, the company provides FortiSandbox advanced threat protection solutions; and FortiDDos and FortiDB database security appliances. Further, it offers security subscription, technical support, training, and professional services. The company was founded in 2000 and is headquartered in Sunnyvale, California.http://www.priceseries.com/trade/FTNT-Fortinet-Inc-stock-gains-26-percent-a-Trade-Record-by-priceSeries-2020050520200527.html

FSM Fortuna Silver Mines Inc. gains 53% May 27, 2020

Fortuna Silver Mines Inc. engages in the exploration, extraction, and processing of mineral properties in Latin America. The company explores for silver, gold, lead, and zinc deposits. It holds interests in the Caylloma mine located in the Arequipa Department in southern Peru; and the San Jose mine located in the State of Oaxaca in southern Mexico. The company was formerly known as Fortuna Ventures Inc. and changed its name to Fortuna Silver Mines Inc. in June 2005. Fortuna Silver Mines Inc. was incorporated in 1990 and is headquartered in Vancouver, Canada.http://www.priceseries.com/trade/FSM-Fortuna-Silver-Mines-Inc-stock-gains-53-percent-a-Trade-Record-by-priceSeries-2020042220200527.html

DVAX Dynavax Technologies Corp. gains 22% May 22, 2020

Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation. Its product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. The company's lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, an investigational cancer immunotherapeutic that is in Phase I/II studies. Its product candidates also comprise AZD1419, which is in Phase II clinical trial for the treatment of asthma; DV230F that is in preclinical stage for the treatment of liver tumors; and DV1001, a TLR 7&8 agonist, which is in preclinical stage for the treatment of for multiple malignancies, as well as DV281 for the treatment of non-small cell lung cancer. It has collaboration and license agreements with AstraZeneca AB to develop AZD1419 for the treatment of asthma; and Merck & Co. to develop SD-101 for varios immuno-oncology therapies. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.http://www.priceseries.com/trade/DVAX-Dynavax-Technologies-Corp-stock-gains-22-percent-a-Trade-Record-by-priceSeries-2020051420200522.html

CRL Charles River Laboratories Intl., Inc. gains 15% May 27, 2020

Charles River Laboratories International, Inc., an early-stage contract research company, provides drug discovery and development services worldwide. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support (Manufacturing). The RMS segment produces and sells research model strains primarily genetically and microbiologically defined purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening preclinical drug candidates comprising genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for identification of a druggable target through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, which comprise bioanalysis, pharmacokinetics, drug metabolism, toxicology, and pathology services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile biopharmaceuticals, and consumer products. This segment also offers specialized testing of biologics and devices that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free fertile chicken eggs and chickens used in the manufacture of live viruses. The company serves pharmaceutical and biotechnology companies, contract research organizations, agricultural and chemical companies, life science and veterinary medicine companies, contract manufacturing organizations, medical device companies, diagnostic and other commercial entities, hospitals, academic institutions, and government agencies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.http://www.priceseries.com/trade/CRL-Charles-River-Laboratories-Intl-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020050620200527.html

COUP Quotient Technology Inc gains 47% May 27, 2020

N/Ahttp://www.priceseries.com/trade/COUP-Quotient-Technology-Inc-stock-gains-47-percent-a-Trade-Record-by-priceSeries-2020041320200527.html

CMG Chipotle Mexican Grill, Inc. gains 44% May 27, 2020

Chipotle Mexican Grill, Inc., together with its subsidiaries, develops and operates Chipotle Mexican Grill restaurants. As of December 31, 2016, the company operated 2,198 Chipotle restaurants throughout the United States, as well as 29 international Chipotle restaurants; and 23 restaurants with non-Chipotle concepts. The company was founded in 1993 and is based in Denver, Colorado.http://www.priceseries.com/trade/CMG-Chipotle-Mexican-Grill-Inc-stock-gains-44-percent-a-Trade-Record-by-priceSeries-2020040620200527.html

CDE Coeur Mining, Inc. gains 15% May 27, 2020

Coeur Mining, Inc. owns, operates, explores for, and develops silver and gold properties. The company holds interests in the Palmarejo silver and gold mine located in Mexico; the Rochester silver and gold mine in northwestern Nevada; the Kensington gold mine located to the north of Juneau, Alaska; and the Wharf gold mine in South Dakota. It also owns interests in the San Bartolome silver mine in Bolivia; the Endeavor zinc, lead, and silver mine located in Australia; the La Preciosa silver-gold exploration project in the State of Durango, Mexico; and the Joaquin silver-gold exploration project located in the Santa Cruz province of southern Argentina. Coeur Mining, Inc. markets its silver and gold concentrates to third-party refiners and smelters in the United States, China, and Japan. The company was formerly known as Coeur d'Alene Mines Corporation and changed its name to Coeur Mining, Inc. in May 2013. Coeur Mining, Inc. was founded in 1928 and is based in Chicago, Illinois.http://www.priceseries.com/trade/CDE-Coeur-Mining-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2020051420200527.html

AMRS Amyris, Inc. gains 26% May 27, 2020

Amyris, Inc. provides various alternatives to a range of petroleum-sourced products worldwide. The company uses its industrial bioscience technology to design microbes primarily yeast, as well as to convert plant-sourced sugars into renewable hydrocarbons. It produces and sells Biofene that converts to squalane, which is used as an emollient in cosmetics and other personal care products; and natural oils and aroma chemicals for the flavors and fragrances market. The company also provides renewable solvents, polymers, and renewable lubricants for industrial applications; and renewable fuels for transportation fuels market. It has a collaboration partnership with Total S.A. to produce and commercialize Biofene-based diesel and jet fuels. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was founded in 2003 and is headquartered in Emeryville, California.http://www.priceseries.com/trade/AMRS-Amyris-Inc-stock-gains-26-percent-a-Trade-Record-by-priceSeries-2020050820200527.html

VUZI Vuzix Corp. gains 33% May 19, 2020

Vuzix Corporation designs, manufactures, markets, and sells wearable display devices in the United States and internationally. The company's products are worn like eyeglasses that enable the user to view video and digital content, such as movies, computer data, the Internet, or video games. Its products include binocular wearable displays that contain two micro displays mounted in a frame attached to eyeglass-style temples or stereo headphones; monocular smart glasses products for the enterprise, industrial, and commercial markets, as well as video headphones; augmented reality products, which provide the user a live, direct or indirect, view of a physical, and real-world environment; and video viewing glasses as mobile displays for entertainment and gaming for on-the-go users, as well as support for stepping into virtual worlds, simulations, and virtual reality gaming. The company sells its products under the Vuzix brand name. Vuzix Corporation offers its products directly to consumers, as well as through specialty retailers, online retailers, distributors, resellers, and Web stores. The company was formerly known as Icuiti Corporation and changed its name to Vuzix Corporation in 2007. Vuzix Corporation was founded in 1997 and is based in West Henrietta, New York.http://www.priceseries.com/trade/VUZI-Vuzix-Corp-stock-gains-33-percent-a-Trade-Record-by-priceSeries-2020050520200519.html

MDGS Medigus Ltd. gains 137% May 15, 2020

Medigus Ltd., a medical device company, engages in the research and development of endoscopic procedures and devices. It offers the MUSE endoscopy system comprising surgical stapler, miniature camera, and ultrasound sensor sensor for the treatment of gastroesophageal reflux disease. The company was founded in 1999 and is based in Omer, Israel.http://www.priceseries.com/trade/MDGS-Medigus-Ltd-stock-gains-137-percent-a-Trade-Record-by-priceSeries-2020042120200515.html

FNV Franco-Nevada Corp. gains 25% May 21, 2020

Franco-Nevada Corporation operates as a gold-focused royalty and stream company in the United States, Canada, Mexico, Peru, Chile, and Africa. The company also has interests in silver; platinum group metals, including palladium; other minerals, including base metals, iron ore, coal, and industrial and miscellaneous minerals; and oil and gas properties. As of March 21, 2017, it had a portfolio of 259 mineral assets and 80 oil and gas assets. Franco-Nevada Corporation was incorporated in 2007 and is headquartered in Toronto, Canada.http://www.priceseries.com/trade/FNV-Franco-Nevada-Corp-stock-gains-25-percent-a-Trade-Record-by-priceSeries-2020040920200521.html

CENTA Central Garden & Pet Company gains 27% May 21, 2020

Central Garden & Pet Company, together with its subsidiaries, produces and markets products for the pet, and lawn and garden supplies industries in the United States. It operates through two segments, Pet and Garden. The Pet segment supplies products for dogs and cats comprising edible bones, edible and non-edible chews, rawhide, dog and cat food and treats, toys, pet carriers, grooming supplies, and other accessories; and food, cages and habitats, toys, chews, and related accessories for birds, small animals, and specialty pets. It also offers animal and household health, and insect control products; aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food and supplements, and information and knowledge resources for fish, reptiles, and other aquarium-based pets; and products for horses and livestock. This segment sells its products to independent pet distributors, retail chains, grocery stores, mass merchants, and bookstores under the Adams, Aqueon, Avoderm, Bio Spot Active Care, Cadet, Farnam, Four Paws, Kaytee, Nylabone, Pinnacle, TFH, Zilla, Altosid, Comfort Zone, Coralife, Interpet, Kent Marine, Pet Select, Super Pet, and Zodiac brands. The Garden segment provides grass seeds; wild bird feed, bird feeders, insect control products, bird houses, and other birding accessories; weed, grass, ant and other herbicide, insecticide, and pesticide products; and decorative outdoor lifestyle products, such as pottery, trellises, and other wood products. This segment sells its products to retail chains, independent garden distributors, grocery stores, nurseries, and garden supply retailers under the AMDRO, Ironite, Pennington, Sevin, Lilly Miller, Over-N-Out, Smart Seed, and The Rebels brands. The company is also involved in the distribution of third party pet, and lawn and garden products. Central Garden & Pet Company was founded in 1955 and is based in Walnut Creek, California.http://www.priceseries.com/trade/CENTA-Central-Garden-&-Pet-Company-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2020040120200521.html

CENT Central Garden & Pet Company gains 27% May 21, 2020

Central Garden & Pet Company, together with its subsidiaries, produces and markets products for the pet, and lawn and garden supplies industries in the United States. It operates through two segments, Pet and Garden. The Pet segment supplies products for dogs and cats comprising edible bones, edible and non-edible chews, rawhide, dog and cat food and treats, toys, pet carriers, grooming supplies, and other accessories; and food, cages and habitats, toys, chews, and related accessories for birds, small animals, and specialty pets. It also offers animal and household health, and insect control products; aquariums, furniture and lighting fixtures, pumps, filters, water conditioners, food and supplements, and information and knowledge resources for fish, reptiles, and other aquarium-based pets; and products for horses and livestock. This segment sells its products to independent pet distributors, retail chains, grocery stores, mass merchants, and bookstores under the Adams, Aqueon, Avoderm, Bio Spot Active Care, Cadet, Farnam, Four Paws, Kaytee, Nylabone, Pinnacle, TFH, Zilla, Altosid, Comfort Zone, Coralife, Interpet, Kent Marine, Pet Select, Super Pet, and Zodiac brands. The Garden segment provides grass seeds; wild bird feed, bird feeders, insect control products, bird houses, and other birding accessories; weed, grass, ant and other herbicide, insecticide, and pesticide products; and decorative outdoor lifestyle products, such as pottery, trellises, and other wood products. This segment sells its products to retail chains, independent garden distributors, grocery stores, nurseries, and garden supply retailers under the AMDRO, Ironite, Pennington, Sevin, Lilly Miller, Over-N-Out, Smart Seed, and The Rebels brands. The company is also involved in the distribution of third party pet, and lawn and garden products. Central Garden & Pet Company was founded in 1955 and is based in Walnut Creek, California.http://www.priceseries.com/trade/CENT-Central-Garden-&-Pet-Company-stock-gains-27-percent-a-Trade-Record-by-priceSeries-2020040120200521.html

AZN Astrazeneca PLC gains 20% May 15, 2020

AstraZeneca PLC engages in the discovery, development, manufacture, and commercialization of prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases worldwide. Its marketed products comprise Arimidex, Casodex/Cosudex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Imdur, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic diseases. The company's marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalent and Synagis for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, Vimovo1, and Zomig for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases. It serves primary care and specialty care physicians through distributors and local representative offices. The company's pipeline includes 132 projects, of which 120 are in the clinical phase of development. It has collaboration agreements with Valeant Holdings Ireland, and Eli Lilly and Company; definitive agreement with Foundation Medicine, Inc.; strategic collaboration with FibroGen and Astellas; collaboration and license agreement with Celgene International Sarl; and license agreement with LEO Pharma A/S. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was founded in 1992 and is headquartered in Cambridge, the United Kingdom.http://www.priceseries.com/trade/AZN-Astrazeneca-PLC-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2020040820200515.html

AEM Agnico Eagle Mines Ltd. gains 55% May 21, 2020

Agnico Eagle Mines Limited engages in the exploration, development, and production of mineral properties in Canada, Finland, and Mexico. It operates through three segments: Northern Business, Southern Business, and Exploration. The company primarily produces and sells gold, as well as explores for silver, zinc, and copper. Its flagship property is the LaRonde mine located in the Abitibi region of northwestern Quebec, Canada. As of December, 31, 2016, the LaRonde mine had a proven and probable mineral reserve of approximately 3.05 million ounces of gold. The company has exploration activities in Canada, Europe, Latin America, and the United States. Agnico Eagle Mines Limited was founded in 1953 and is headquartered in Toronto, Canada.http://www.priceseries.com/trade/AEM-Agnico-Eagle-Mines-Ltd-stock-gains-55-percent-a-Trade-Record-by-priceSeries-2020040120200521.html

ACER ACER Therapeutics Inc. gains 54% May 21, 2020

Opexa Therapeutics, Inc., a biopharmaceutical company, develops personalized immunotherapy to treat multiple sclerosis (MS) and other autoimmune diseases based on its proprietary T-cell technology. The company's lead product candidate is Tcelna, a novel T-cell immunotherapy, which is in Phase IIb clinical development for the treatment of patients with secondary progressive MS. It is also developing OPX-212 as an autologous T-cell immunotherapy that is in preclinical development to treat neuromyelitis optica. The company was formerly known as PharmaFrontiers Corp. and changed its name to Opexa Therapeutics, Inc. in June 2006. Opexa Therapeutics, Inc. was founded in 2003 and is based in The Woodlands, Texas.http://www.priceseries.com/trade/ACER-ACER-Therapeutics-Inc-stock-gains-54-percent-a-Trade-Record-by-priceSeries-2020050620200521.html

VICR Vicor Corp. gains 18% May 14, 2020

Vicor Corporation designs, develops, manufactures, and markets modular components and power systems for converting, regulating, and controlling electric current worldwide. It operates through Brick Business Unit, VI Chip, and Picor segments. The company offers modular direct current (DC)-DC converters and complementary components, open-frame intermediate bus converters, configurable products, and custom power systems, as well as cool-power high density zero voltage soft switching DC-DC converters. It also provides modular power components, Vicor integrated adapter packages, system-in-package point-of-load regulators, and power path management components. The company serves independent manufacturers of electronic devices, original equipment manufacturers, and their contract manufacturers in aerospace and aviation, defense electronics, enterprise and high performance computing, industrial automation, medical diagnostics, test and measurement instrumentation, and vehicles and transportation, as well as telecommunications and network equipment and infrastructure markets. Vicor Corporation was founded in 1981 and is headquartered in Andover, Massachusetts.http://www.priceseries.com/trade/VICR-Vicor-Corp-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2020042320200514.html

VLO Valero Energy Corp. gains 21% May 14, 2020

Valero Energy Corporation operates as an independent petroleum refining and ethanol producing company in the United States, Canada, the United Kingdom, and Ireland. It operates through two segments, Refining and Ethanol. The company is involved in refining, marketing, and bulk sales activities. It produces conventional and premium gasolines, gasoline meeting the specifications of the California Air Resources Board (CARB), diesel fuels, low-sulfur and ultra-low-sulfur diesel fuels, CARB diesel fuels, distillates, jet fuels, asphalts, petrochemicals, lubricants, and other refined products. As of December 31, 2016, the company owned 15 petroleum refineries with a combined throughput capacity of approximately 3.1 million barrels per day. It markets its refined products through wholesale rack and bulk markets; and through approximately 7,400 outlets under the Valero, Diamond Shamrock, Shamrock, Ultramar, Beacon, and Texaco brand names. The company also produces and sells ethanol, distiller grains, and corn oil primarily to refiners and gasoline blenders, as well as to animal feed customers. It owns and operates 11 ethanol plants with a combined ethanol production capacity of approximately 1.4 billion gallons per year. In addition, it operates a 50-megawatt wind farm; convenience stores; gas stations; and truckstop and cardlock facilities, as well as engages in the credit card business. The company was formerly known as Valero Refining and Marketing Company and changed its name to Valero Energy Corporation in August 1997. Valero Energy Corporation was founded in 1955 and is headquartered in San Antonio, Texas.http://www.priceseries.com/trade/VLO-Valero-Energy-Corp-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2020042120200514.html

USAT USA Technologies, Inc. gains 20% May 8, 2020

USA Technologies, Inc. provides wireless networking, cashless transactions, asset monitoring, and other value-added services principally to the small ticket and unattended point of sale (POS) markets in the United States and internationally. The company designs and markets systems and solutions that facilitate electronic payment options, as well as telemetry and machine-to-machine (M2M) services to remotely monitor, control, and report on the results of distributed assets containing its electronic payment solutions. Its ePort Connect solution offers POS options, card processing services, wireless connectivity, online sales reporting, M2M telemetry and DEX data transfer, over-the-air update capabilities, deployment planning, and value-added services, as well as premium services comprising planning, project management, installation support, marketing, and performance evaluation. The company's products include ePort, a device that is used in self-service, unattended markets comprising vending, amusement and arcade, and various other kiosk applications, as well as facilitates cashless payments by capturing payment information and transmitting it to its network for authorization with the payment system. USA Technologies, Inc. was founded in 1992 and is headquartered in Malvern, Pennsylvania.http://www.priceseries.com/trade/USAT-USA-Technologies-Inc-stock-gains-20-percent-a-Trade-Record-by-priceSeries-2020042320200508.html

TOL Toll Brothers Inc. gains 17% May 13, 2020

Toll Brothers, Inc., together with its subsidiaries, designs, builds, markets, and arranges finance for detached and attached homes in luxury residential communities. The company operates through two segments, Traditional Home Building and City Living. It also builds and sells homes in urban infill markets under the Toll Brothers City Living name. In addition, the company develops, owns, and operates golf courses and country clubs that are associated with various master planned communities; develops and sells land to other builders; and develops, operates, and rents apartments. The company serves move-up, empty-nester, active-adult, age-qualified, and second-home buyers in 19 states in the United States. Toll Brothers, Inc. was founded in 1967 and is headquartered in Horsham, Pennsylvania.http://www.priceseries.com/trade/TOL-Toll-Brothers-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2020042320200513.html

TMHC Taylor Morrison Home Corp. gains 16% May 13, 2020

Taylor Morrison Home Corporation operates as a public homebuilder in the United States. The company designs, builds, and sells single-family detached and attached homes; and develops lifestyle and master planned communities. It operates under the Taylor Morrison and Darling Homes brands in Arizona, California, Colorado, Florida, Georgia, Illinois, North Carolina and Texas. The company also offers mortgage and title services, as well as financial services. Taylor Morrison Home Corporation was founded in 1936 and is headquartered in Scottsdale, Arizona.http://www.priceseries.com/trade/TMHC-Taylor-Morrison-Home-Corp-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2020042720200513.html